QUOTE AND NEWS
SeekingAlpha  Jul 23  Comment 
The Medicines Company (NASDAQ:MDCO) Q2 2014 Results Earnings Conference Call July 23, 2014, 08:30 AM ET Executives Neera Dahiya Ravindran - IR Clive Meanwell - CEO Glenn Sblendorio - President and CFO Cees Heiman - CIO and EVP ...
Motley Fool  Jul 18  Comment 
MiMedx, The Medicines Company, and Pacira Therapeutics should all see huge leaps in their earnings going forward. Here's what you need to know.
Market Intelligence Center  Jul 15  Comment 
After Monday’s trading in Medicines Company (MDCO) the algorithms behind MarketIntelligenceCenter.com's Artifical Intelligence Center picked out a trade that offers a 6.56% or 25.19% (for comparison purposes only), while providing 10.29%...
Forbes  Jul 7  Comment 
Although there is broad consensus in the medical community that immediate stenting (primary PCI) is the best treatment for heart attack patients when it can be delivered promptly, there is no agreement about the best accompanying drug regimen,...
StreetInsider.com  Jul 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Medicines+Co.+%28MDCO%29+Receives+CHMP+Marketing+Authorization+for+Angiox/9641104.html for the full story.
Market Intelligence Center  Jul 2  Comment 
Medicines Company (MDCO) is a good candidate for a covered call at the $29.00 level. The Oct. '14 call at that price should fetch a credit of about $2.25, which means the entire position has a net debit of about $27.26. This trade has 4.44%...
Market Intelligence Center  Jun 13  Comment 
Medicines Company (MDCO) was selected by MarketIntelligenceCenter.com’s trade-picking algorithms today after trading between $27.90 and $28.50 on Thursday before closing at $28.04. A diagonal spread using a long position in the Jan. '15 $18.00...
DailyFinance  Jun 5  Comment 
The Medicines Company (NASDAQ:MDCO) today announced the publication of the results from the SOLO I Phase 3 clinical trial of ORBACTIVTM (oritavancin), an investigational intravenous antibiotic treatment for Acute Bacterial...
Market Intelligence Center  Jun 5  Comment 
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artifical Intelligence Center found a trading opportunity with Medicines Company (MDCO) that should provide a 8.78% return in just 135 days. Buy one Oct. '14...
DailyFinance  Jun 4  Comment 
The Medicines Company (NASDAQ:MDCO) is scheduled to present at the Goldman Sachs 35th Annual Global Healthcare Conference in Rancho Palos Verdes, CA on Tuesday, June 10th at 1:20 PM Pacific Time / 4:20 PM Eastern Time. ...




RELATED WIKI ARTICLES
 

Based in Parsippany, NJ, The Medicines Company (MDCO) is engaged in acquiring, developing, and marketing specialty pharmaceutical primarily for cardiovascular indications. Its leading product, Angiomax (bivalirudin), which was acquired from Biogen Idec, Inc. in 1996, is used as an anticoagulant in patients undergoing coronary angioplasty. The company's other late-stage products include Clevidipine and Cangrelor, both acquired from AstraZeneca several years ago. Clevidipine is an intravenous drug (calcium channel blocker) intended for the short-term control of blood pressure in patients undergoing cardiac surgery. Cangrelor is an intravenous anticoagulant, having potential uses in coronary angioplasty and cardiac surgery. The company sells its products through its own sales force and distributors. In 2006, sales of Angiomax helped generate $214.0 million revenue.




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki